• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PC1
Click for more information
9.09% 1.0¢

PLUS CONNECT LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
PC1 Response to ASX volume queryPRICE SENSITIVE27/04/12
PC1 Half Year Financial Report and Appendix 4DPRICE SENSITIVE28/02/12
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/12
PC1 PROPOSED DIAGNOSTIC TECHNOLOGY ACQUISITIONPRICE SENSITIVE25/01/12
PC1 Proposed BioHealth AcquisitionPRICE SENSITIVE01/12/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE27/10/11
PC1 Preliminary Final ReportPRICE SENSITIVE30/08/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE29/07/11
PC1 Proposed capital raisingPRICE SENSITIVE27/05/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/04/11
PC1 Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE28/02/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE27/10/10
PC1 Preliminary Financial ReportPRICE SENSITIVE30/08/10
PC1 Non-Renounceable Issue - Offer DocumentPRICE SENSITIVE27/08/10
PC1 s708A NoticePRICE SENSITIVE23/08/10
PC1 Hawaii Biotech Inc UpdatePRICE SENSITIVE23/07/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE08/07/10
PC1 Business Update - HBI and Proposed Capital RaisingPRICE SENSITIVE30/06/10
PC1 Non-Renounceable Rights Issue - shareholder letterPRICE SENSITIVE04/05/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/04/10
PC1 Acuvax Undertakes Share PlacementPRICE SENSITIVE23/03/10
PC1 Appendix 4D and Half Year AccountsPRICE SENSITIVE26/02/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/01/10
PC1 HBI Completes Phase 1 TrialPRICE SENSITIVE11/01/10
PC1 Acuvax Affliate Receives Capital InjectionPRICE SENSITIVE22/12/09
PC1 Acuvax Affiliate ReorganisesPRICE SENSITIVE14/12/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/10/09
PC1 Acuvax Affiliate Sales Top USD$1M in 2009PRICE SENSITIVE08/10/09
PC1 RP101 Clinical TrialsPRICE SENSITIVE06/10/09
PC1 Share Purchase PlanPRICE SENSITIVE21/09/09
PC1 Placement and Resignation of a DirectorPRICE SENSITIVE17/09/09
PC1 Preliminary Final ReportPRICE SENSITIVE31/08/09
PC1 First Human Trials for Recombinant Dengue Fever VaccinePRICE SENSITIVE26/08/09
PC1 Acuvax Advances Technology Collaboration and Capital RaisingPRICE SENSITIVE21/08/09
PC1 Affiliate Wins Major Grant to Fight Tick Borne EncephalitisPRICE SENSITIVE12/08/09
PC1 Commitments Test Entity - Fourth Quarter ReportPRICE SENSITIVE31/07/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/04/09
PC1 Acuvax Takes Cash Gain on Portion of Oncology AssetsPRICE SENSITIVE15/04/09
PC1 Acuvax Oncology Portfolio Advances in the USAPRICE SENSITIVE19/03/09
PC1 Half Yearly Report and AccountsPRICE SENSITIVE27/02/09
PC1 Hawaii Biotech Favorable Interim Results for West Nile VirusPRICE SENSITIVE26/02/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE29/01/09
PC1 West Nile Dosing Trials Completed. Avantogen now AcuvaxPRICE SENSITIVE17/12/08
PC1 Draw Down Facility with Fortrend SecuritiesPRICE SENSITIVE03/12/08
PC1 Response to ASX volume query
27/04/12PRICE SENSITIVE
PC1 Half Year Financial Report and Appendix 4D
28/02/12PRICE SENSITIVE
PC1 Appendix 4C - quarterly
31/01/12PRICE SENSITIVE
PC1 PROPOSED DIAGNOSTIC TECHNOLOGY ACQUISITION
25/01/12PRICE SENSITIVE
PC1 Proposed BioHealth Acquisition
01/12/11PRICE SENSITIVE
PC1 Appendix 4C - quarterly
27/10/11PRICE SENSITIVE
PC1 Preliminary Final Report
30/08/11PRICE SENSITIVE
PC1 Appendix 4C - quarterly
29/07/11PRICE SENSITIVE
PC1 Proposed capital raising
27/05/11PRICE SENSITIVE
PC1 Appendix 4C - quarterly
28/04/11PRICE SENSITIVE
PC1 Appendix 4D - Half Yearly Report and Accounts
28/02/11PRICE SENSITIVE
PC1 Appendix 4C - quarterly
31/01/11PRICE SENSITIVE
PC1 Appendix 4C - quarterly
27/10/10PRICE SENSITIVE
PC1 Preliminary Financial Report
30/08/10PRICE SENSITIVE
PC1 Non-Renounceable Issue - Offer Document
27/08/10PRICE SENSITIVE
PC1 s708A Notice
23/08/10PRICE SENSITIVE
PC1 Hawaii Biotech Inc Update
23/07/10PRICE SENSITIVE
PC1 Appendix 4C - quarterly
08/07/10PRICE SENSITIVE
PC1 Business Update - HBI and Proposed Capital Raising
30/06/10PRICE SENSITIVE
PC1 Non-Renounceable Rights Issue - shareholder letter
04/05/10PRICE SENSITIVE
PC1 Appendix 4C - quarterly
30/04/10PRICE SENSITIVE
PC1 Acuvax Undertakes Share Placement
23/03/10PRICE SENSITIVE
PC1 Appendix 4D and Half Year Accounts
26/02/10PRICE SENSITIVE
PC1 Appendix 4C - quarterly
28/01/10PRICE SENSITIVE
PC1 HBI Completes Phase 1 Trial
11/01/10PRICE SENSITIVE
PC1 Acuvax Affliate Receives Capital Injection
22/12/09PRICE SENSITIVE
PC1 Acuvax Affiliate Reorganises
14/12/09PRICE SENSITIVE
PC1 Appendix 4C - quarterly
30/10/09PRICE SENSITIVE
PC1 Acuvax Affiliate Sales Top USD$1M in 2009
08/10/09PRICE SENSITIVE
PC1 RP101 Clinical Trials
06/10/09PRICE SENSITIVE
PC1 Share Purchase Plan
21/09/09PRICE SENSITIVE
PC1 Placement and Resignation of a Director
17/09/09PRICE SENSITIVE
PC1 Preliminary Final Report
31/08/09PRICE SENSITIVE
PC1 First Human Trials for Recombinant Dengue Fever Vaccine
26/08/09PRICE SENSITIVE
PC1 Acuvax Advances Technology Collaboration and Capital Raising
21/08/09PRICE SENSITIVE
PC1 Affiliate Wins Major Grant to Fight Tick Borne Encephalitis
12/08/09PRICE SENSITIVE
PC1 Commitments Test Entity - Fourth Quarter Report
31/07/09PRICE SENSITIVE
PC1 Appendix 4C - quarterly
28/04/09PRICE SENSITIVE
PC1 Acuvax Takes Cash Gain on Portion of Oncology Assets
15/04/09PRICE SENSITIVE
PC1 Acuvax Oncology Portfolio Advances in the USA
19/03/09PRICE SENSITIVE
PC1 Half Yearly Report and Accounts
27/02/09PRICE SENSITIVE
PC1 Hawaii Biotech Favorable Interim Results for West Nile Virus
26/02/09PRICE SENSITIVE
PC1 Appendix 4C - quarterly
29/01/09PRICE SENSITIVE
PC1 West Nile Dosing Trials Completed. Avantogen now Acuvax
17/12/08PRICE SENSITIVE
PC1 Draw Down Facility with Fortrend Securities
03/12/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Chris Judd’s Talk Ya Book: Predictive Discovery finally coming to its 'pointy end' - and it's gunning for gold On Chris Judd’s Talk Ya Book today, Emanuel Datt from Datt Capital @ one of the most highly requested analysts on Judd’s show @ breaks down why he believes Predictive Discovery (ASX:PDI) is perfectly placed to capitalise on gold’s glittering run.Gol...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.